TheJobsMapSonoma Biotherapeutics jobs and careers
About Sonoma Biotherapeutics
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.
Founded in 2020 by Alexander Rudensky, Fred Ramsdell, Jeffrey Bluestone and Qizhi Tang.
- Founded
- 2020
- Employees
- 101 to 250
- Total funding
- $365M
- Hiring in
- 1 city
Leadership
The top of Sonoma Biotherapeutics's org chart, with how many people report into each leader.
Fred Ramsdell
Chief Scientific Officer
32 reports
Jessica Stitt
CFO
3 reports
Lisa Taylor Ash
Chief Legal Officer
2 reports
Dale Kopp
Director of Quality Control
Nolan Reile
Associate Director Quality Systems
Jia Wei
Senior Principal Scientist
9 reports
Frederic Van Gool
Senior Director
2 reports
Mei-Lun Wang
Senior Vice President, Clinical Development
18 reports
Jillian McGuire
Head of Finance
2 reports
Anavelys Ortiz-Suarez
Head, Intellectual Property & Legal Operations
1 report
Board
Rick Klausner
Chairman
Toni Hoover
Board Member
Terry Rosen
Board Member
Maggie Wilderotter
Board Member
Frank Yu
Board Member
John C. Davis Jr.
Board Member